PATHFINDER 2: A Multi-Cancer Early Detection Study

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PATHFINDER 2: A Multi-Cancer Early Detection Study	cancer, neoplasm	Active, not recruiting	Not applicable	2026-05-14		NCT05155605

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
GRAIL, Inc.	5

56 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cleveland Clinic	Cleveland	United States	558
Duke University Health System	Durham	United States	15
Eastern Virginia Medical School	Norfolk	United States	4
Flushing Hospital Medical Center	Queens	United States	1
Henry Ford Health System	Detroit	United States	147
Henry Ford Macomb	Clinton	United States	1
Henry Ford Medical Center Detroit North West	Detroit	United States	1
Henry Ford Medical Center Ford Road	Dearborn	United States	1
Henry Ford Medical Center Harbortown	Detroit	United States	1
Henry Ford Medical Center Sterling Heights	Sterling Heights	United States	1
HOAG Irvine	Irvine	United States	1
HOAG Newport Beach	Newport Beach	United States	1
HOAG Vivante Newport Mesa	Irvine	United States	1
Inova	Fairfax	United States	2
Jamaica Hospital Medical Center	Queens	United States	2
Kelsey-Seybold Clinic Cypress Woods	Houston	United States	1
Kelsey-Seybold Clinic Holcombe	Houston	United States	1
Long Beach Memorial Medical Center	Long Beach	United States	14
Maryland Oncology Hematology	Annapolis	United States	3
Mayo Clinic - Cancer Center	Rochester	United States	1
Medstar Washington Hospital Center	Northwest	United States	1
Morehouse School of Medicine	Atlanta	United States	22
Northwest Cancer Specialists	Vancouver	United States	4
Ochsner Grove	Baton Rouge	United States	1
Ochsner Health	New Orleans	United States	1

Clinical trials